[1]戴政文,杨功旭△,邓小川,等.健骨汤治疗早中期膝骨性关节炎的临床研究[J].中国中医骨伤科杂志,2015,23(03):26-28.
　DAI Zhengwen,YANG Gongxu,DENG Xiaocuan,et al.The Clinical Study Of JIANGGU Decoction on Preventing and Treating the Early Metaphase Knee Joint Osteoarthritis[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2015,23(03):26-28.
点击复制

健骨汤治疗早中期膝骨性关节炎的临床研究
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第23卷
期数:
2015年03期
页码:
26-28
栏目:
临床研究
出版日期:
2015-03-15

文章信息/Info

Title:
The Clinical Study Of JIANGGU Decoction on Preventing and Treating the Early Metaphase Knee Joint Osteoarthritis
文章编号:
1005-0205(2015)03-0026-03
作者:
戴政文1; 杨功旭1△; 邓小川1;
1湖北省中医院骨科(武汉,430074)
△通讯作者 E-mail:tcdyanggx@sina.com
Author(s):
DAI Zhengwen1; YANG Gongxu1; DENG Xiaocuan1;
1Hubei Provincial Hospital Of TCM, Wuhan 430074, China
关键词:
关节软骨;  健骨汤;  膝关节;  骨性关节炎
Keywords:
articular cartilage;  Jiangu decoction;  knee joint;  osteoarthritis
分类号:
R684.3
文献标志码:
A
摘要:
目的:探讨健骨汤治疗早中期膝骨性关节炎的临床疗效。方法:回顾性分析2012年1月-2013年12月我院骨科门诊膝骨性关节炎患者,共160例,根据治疗方法分为治疗组与对照组各80例。治疗组予健骨汤,对照组口服硫酸氨基葡萄糖胶囊。3周为1疗程,观察患肢膝关节VAS评分和WOMAS指数,并进行疗效评价。结果:1疗程后,两组VAS评分较治疗前降低,差异有统计学意义(P<0.05); 治疗后WOMAS指数明显改善,差异有统计学意义(P<0.01); 治疗组总体疗效优于对照组(P<0.05)。结论:健骨汤治疗早中期膝骨性关节炎具有较好疗效,值得临床进一步推广使用。
Abstract:
To observe the clinical effect of Jiangu decoction on treating knee joint osteoarthritis in early metaphase. Methods:The clinical data of 160 patients with knee joint osteoarthritis at our hospital between January 2012 and December 2013 were retrospectively reviewed.The patients were randomly divided into the treatment group(n=80)and were the control group(n=80)to be treated with the Jiangu decoction and the Glucosamine gluecosamine sulfate respectively for 3 weeks. The changes of the VAS score and WOMAS index in both groups were assessed. Results:After 3 weeks' treatment, there were significant differences between the two groups on the VAS score(P<0.05)and WOMAS index(P<0.01). The efficacy of Jiangu Decoction Group was superior to that of the Glucosamine Group(P<0.05). Conclusions:Jiangu decoction has favorable therapeutic effects on knee joint osteoarthritis in early metaphase, and it make a good clinical guidance.

参考文献/References:

[1] 中华医学会骨科学分会. 骨关节炎诊治指南(2007年版)[J]. 中华关节外科杂志(电子版).2007,1(4):281-285.
[2] HOLDEN D L,JAMES S L,LARSON R L,et al.Proximal tibial osteotomy in patients who are fifty years old or less. A long-term follow-up study[J]. J Bone Joint Surg Am,1988,70(7):977-982.
[3] JENSEN M P,KAROLY P,BRAVER S.The measurement of clinical pain intensity:a comparison of six methods[J]. Pain,1986,27(1):117-126.
[4] BELLAMY N,BUCHANAN W W,GOLDSMITH C H,et al.Validation study of WOMAC:a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee[J]. J Rheumatol,1988,15(12):1833-1840.
[5] 中药新药临床研究指导原则(试行)[M].北京:中国医药科技出版社,2002:349-353.
[6] 薛森海,王治伦,杨浩杰.基质金属蛋白酶及细胞因子在骨关节炎发病机制中的研究[J]. 中国地方病防治杂志,2007,22(6):420-423.

备注/Memo

备注/Memo:
收稿日期:2014-09-08
更新日期/Last Update: 2015-03-01